Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty
Completed · Phase 3 · Has a placebo group
Conditions studied: Acute Pain
In brief
The purpose of this study was to evaluate the efficacy and safety of Suzetrigine (SUZ) in treating acute pain after an abdominoplasty.
Key facts
- Study ID
- NCT05558410
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 1118
- Starts
- 2022-10-10
- Expected to finish
- 2023-09-11
- Last updated by the study team
- 2025-07-01
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Shoals Medical Trials Inc. — Sheffield, Alabama, United States
- Arizona Research Center — Phoenix, Arizona, United States
- Woodland International Research Group — Little Rock, Arkansas, United States
- Alliance Research Institute, LLC — Canoga Park, California, United States
- New Hope Research Development — Tarzana, California, United States
- Atlanta Center for Medical Research | Atlanta, GA — Atlanta, Georgia, United States
- Kansas Spine and Specialty Hospital — Wichita, Kansas, United States
- HD Research LLC | First Surgical Hospital — Bellaire, Texas, United States
- HD Research LLC | Houston Heights Hospital — Houston, Texas, United States
- Endeavor Clinical Trials — San Antonio, Texas, United States
- South Texas Spine & Surgical Hospital — San Antonio, Texas, United States
- JBR Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.